Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer

ClinicalTrials.gov ID: NCT04936230

Public ClinicalTrials.gov record NCT04936230. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 7:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Randomized Trial of Immunotherapy Versus Immunotherapy and Radiation Therapy for Platinum Ineligible/Refractory Metastatic Urothelial Cancer (IMMORTAL)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This phase II trial compares the effect of adding radiation therapy to an immunotherapy drug called pembrolizumab versus pembrolizumab alone in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). The addition of radiation to immunotherapy may shrink the cancer, but it could also cause side effects. Immunotherapy with monoclonal antibodies such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Stereotactic body radiation therapy (SBRT) is a type of radiation therapy that uses high energy x-rays to kill tumor cells and shrink tumors. This method uses special equipment to position a patient and precisely deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period and may cause less damage to normal tissue than conventional radiation therapy. The combination of pembrolizumab and radiation therapy may be more efficient in killing tumor cells.

Study identification

NCT ID
NCT04936230
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Enrollment
1 participant

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 22, 2022 (Actual)
Primary completion
Aug 15, 2024 (Actual)
Completion
Aug 15, 2024 (Actual)
Last update posted
Aug 17, 2025

2022 – 2024

United States locations

U.S. sites
83
U.S. states
13
U.S. cities
67
Facility City State ZIP Site status
Littleton Adventist Hospital Littleton Colorado 80122 —
Illinois CancerCare-Bloomington Bloomington Illinois 61704 —
Illinois CancerCare-Canton Canton Illinois 61520 —
Illinois CancerCare-Carthage Carthage Illinois 62321 —
Centralia Oncology Clinic Centralia Illinois 62801 —
Rush University Medical Center Chicago Illinois 60612 —
University of Illinois Chicago Illinois 60612 —
Carle at The Riverfront Danville Illinois 61832 —
Cancer Care Specialists of Illinois - Decatur Decatur Illinois 62526 —
Decatur Memorial Hospital Decatur Illinois 62526 —
Carle Physician Group-Effingham Effingham Illinois 62401 —
Crossroads Cancer Center Effingham Illinois 62401 —
Illinois CancerCare-Eureka Eureka Illinois 61530 —
Illinois CancerCare-Galesburg Galesburg Illinois 61401 —
Illinois CancerCare-Kewanee Clinic Kewanee Illinois 61443 —
Illinois CancerCare-Macomb Macomb Illinois 61455 —
Carle Physician Group-Mattoon/Charleston Mattoon Illinois 61938 —
Cancer Care Center of O'Fallon O'Fallon Illinois 62269 —
HSHS Saint Elizabeth's Hospital O'Fallon Illinois 62269 —
Illinois CancerCare-Ottawa Clinic Ottawa Illinois 61350 —
Illinois CancerCare-Pekin Pekin Illinois 61554 —
Illinois CancerCare-Peoria Peoria Illinois 61615 —
OSF Saint Francis Medical Center Peoria Illinois 61637 —
Illinois CancerCare-Peru Peru Illinois 61354 —
Illinois CancerCare-Princeton Princeton Illinois 61356 —
Southern Illinois University School of Medicine Springfield Illinois 62702 —
Springfield Clinic Springfield Illinois 62702 —
Springfield Memorial Hospital Springfield Illinois 62781 —
Carle Cancer Center Urbana Illinois 61801 —
Illinois CancerCare - Washington Washington Illinois 61571 —
Mission Cancer and Blood - Ankeny Ankeny Iowa 50023 —
Mercy Cancer Center-West Lakes Clive Iowa 50325 —
Greater Regional Medical Center Creston Iowa 50801 —
Iowa Methodist Medical Center Des Moines Iowa 50309 —
Mission Cancer and Blood - Des Moines Des Moines Iowa 50309 —
Broadlawns Medical Center Des Moines Iowa 50314 —
Mercy Medical Center - Des Moines Des Moines Iowa 50314 —
Mercy Medical Center-West Lakes West Des Moines Iowa 50266 —
Trinity Health Saint Joseph Mercy Hospital Ann Arbor Ann Arbor Michigan 48106 —
Trinity Health IHA Medical Group Hematology Oncology - Brighton Brighton Michigan 48114 —
Trinity Health Medical Center - Brighton Brighton Michigan 48114 —
Trinity Health IHA Medical Group Hematology Oncology - Canton Canton Michigan 48188 —
Trinity Health Medical Center - Canton Canton Michigan 48188 —
Chelsea Hospital Chelsea Michigan 48118 —
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital Chelsea Michigan 48118 —
University of Michigan Health - Sparrow Lansing Lansing Michigan 48912 —
Trinity Health Saint Mary Mercy Livonia Hospital Livonia Michigan 48154 —
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus Ypsilanti Michigan 48197 —
Saint Luke's Hospital of Duluth Duluth Minnesota 55805 —
Saint Francis Medical Center Cape Girardeau Missouri 63703 —
MU Health - University Hospital/Ellis Fischel Cancer Center Columbia Missouri 65212 —
Parkland Health Center - Farmington Farmington Missouri 63640 —
Sainte Genevieve County Memorial Hospital Sainte Genevieve Missouri 63670 —
Missouri Baptist Medical Center St Louis Missouri 63131 —
Mercy Hospital Saint Louis St Louis Missouri 63141 —
Missouri Baptist Sullivan Hospital Sullivan Missouri 63080 —
BJC Outpatient Center at Sunset Hills Sunset Hills Missouri 63127 —
Bozeman Health Deaconess Hospital Bozeman Montana 59715 —
NYP/Weill Cornell Medical Center New York New York 10065 —
Cancer Centers of Southwest Oklahoma Research Lawton Oklahoma 73505 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
Geisinger Medical Center Danville Pennsylvania 17822 —
Geisinger Medical Oncology-Lewisburg Lewisburg Pennsylvania 17837 —
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 —
Geisinger Cancer Services-Pottsville Pottsville Pennsylvania 17901 —
Geisinger Wyoming Valley/Henry Cancer Center Wilkes-Barre Pennsylvania 18711 —
UT Southwestern Simmons Cancer Center - RedBird Dallas Texas 75237 —
UT Southwestern/Simmons Cancer Center-Dallas Dallas Texas 75390 —
UT Southwestern/Simmons Cancer Center-Fort Worth Fort Worth Texas 76104 —
UT Southwestern Clinical Center at Richardson/Plano Richardson Texas 75080 —
VCU Massey Cancer Center at Hanover Medical Park Mechanicsville Virginia 23116 —
VCU Massey Cancer Center at Stony Point Richmond Virginia 23235 —
Virginia Commonwealth University/Massey Cancer Center Richmond Virginia 23298 —
Marshfield Medical Center-EC Cancer Center Eau Claire Wisconsin 54701 —
Marshfield Medical Center-Marshfield Marshfield Wisconsin 54449 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —
Marshfield Medical Center - Minocqua Minocqua Wisconsin 54548 —
ProHealth D N Greenwald Center Mukwonago Wisconsin 53149 —
ProHealth Oconomowoc Memorial Hospital Oconomowoc Wisconsin 53066 —
Marshfield Medical Center-Rice Lake Rice Lake Wisconsin 54868 —
Marshfield Medical Center-River Region at Stevens Point Stevens Point Wisconsin 54482 —
UW Cancer Center at ProHealth Care Waukesha Wisconsin 53188 —
Marshfield Medical Center - Weston Weston Wisconsin 54476 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04936230, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 17, 2025 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04936230 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →